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Bone morphogenetic protein-4 (BMP-4) induces epidermis and represses neural fate in Xenopus ectoderm. Our previous
ndings implicate p42 Erk MAP kinase (MAPK) in the response to neural induction. We have examined the effects of BMP-4
n MAPK activity in gastrula ectoderm. Expression of a dominant negative BMP-4 receptor resulted in a 4.5-fold elevation
n MAPK activity in midgastrula ectoderm. MAPK activity was reduced in ectoderm expressing a constitutively active
MP-4 receptor, or ectoderm treated with BMP-4 protein in the presence or absence of cycloheximide. Overexpression of
AK1 led to a reduction in MAPK activity in early gastrula ectoderm. The inhibitory effects of TAK1 could be reversed by
mM SB 203580, a p38 inhibitor. Treatment of isolated ectoderm with SB 203580 led to expression of otx2, NCAM, and
noggin. Western blot analyses indicated that the BMP-4 pathway does not activate JNKs in ectoderm. Our findings indicate
that BMP-4 inhibits ectodermal MAPK activity through a TAK1/p38-type pathway. MAPK has been shown to inactivate
Smad1. Thus, our results suggest that BMP-4 and MAPK pathways are mutually antagonistic in Xenopus ectoderm, and that
interactions between these pathways may govern the choice between epidermal and neural fate. © 2001 Academic Press
Key Words: MAP kinase; BMP-4; TAK1; neural induction; epidermis; FGF; gastrula; embryo; Xenopus.w
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Bone morphogenetic protein-4 (BMP-4) and other TGF-b
family members are critical regulators of many processes in
vertebrate development, including the specification of ec-
todermal fate (reviewed in Weinstein and Hemmati-
Brivanlou, 1999), cell proliferation in the limb bud (Niswan-
der and Martin, 1993), and patterning within the somite
(Amthor et al., 1999), among many others. In each of these
instances, the final developmental outcome is a response to
BMP-4 in concert with other extracellular signals, such as
FGFs, wnts, and hedgehogs. Thus, crosstalk between intra-
cellular signaling pathways could be a key mechanism for
the modulation of specific developmental responses.
Two signaling pathways are activated by signaling
through the BMP-4 receptor complex. The first involves
phosphorylation of the BMP-4 effector Smad1 at the C
terminus; thus phosphorylated, Smad1 binds Smad4, trans-
locates to the nucleus, and participates in transcriptional
regulation (reviewed in Massague, 1998). The second path-
1 Present address: Department of Cell Biology, Baylor College of
Medicine, Houston, TX 77030.
2 To whom correspondence should be addressed. Fax: 713-743-
636. E-mail: asater@uh.edu.
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All rights of reproduction in any form reserved.ay is mediated by TGF-b-activated kinase (TAK1), a
ember of the mitogen-activated protein kinase kinase
inase (MAPKKK) family (Yamaguchi et al., 1995). In mam-
alian cells, TAK1 has been shown to act via either Jun
-terminal kinases (JNKs) (Shirakabe et al., 1997) or p38
Hanafusa et al., 1999), both members of the MAP kinase
amily. In Caenorhabditis elegans, TAK1 activates lit-1, a
omologue of the distantly related MAP kinase family
ember Nemo-like kinase; this pathway culminates in the
nhibitory phosphorylation of TCF-1/Lef-1 and the down-
egulation of wnt/b-catenin-inducible transcription (Me-
neghini et al., 1999). The TAK1/NLK pathway has also been
shown to inhibit wnt/b-catenin-dependent signaling in ver-
ebrates (Ishitani et al., 1999).
In Xenopus embryos, TAK1 has been implicated in the
stablishment of ventral mesoderm in response to BMP-4
Shibuya et al., 1998). Xenopus JNKs are largely uncharac-
erized. A kinase resembling the yeast p38 homologue
OG1 has been isolated from Xenopus oocyte extracts by
ts ability to reactivate MAPKAP2 (Rouse et al., 1994); this
inase, known as MPK2, is the only p38 family member
hus far identified in Xenopus. Although JNKs, NLK, and
38/MPK2 are candidates, downstream effectors of TAK1
ignaling in Xenopus have not been identified.
Our earlier findings indicate that p42 ERK MAP kinase
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260 Goswami, Uzgare, and Sater(referred to as MAP kinase or MAPK) is required for neural
specification in vivo, and that MAP kinase activity is
elevated in newly induced neural ectoderm or ectoderm
expressing the BMP-4 antagonist noggin (Uzgare et al.,
1998). MAP kinase is a primary effector of FGF signals;
thus, our results are consistent with recent findings impli-
cating FGFs as neural inducing signals (Hongo et al., 1999;
Streit et al., 2000; Wilson et al., 2000). Since BMP-4
negatively regulates neural specification (Wilson and
Hemmati-Brivanlou, 1995), we asked whether BMP-4 sig-
nals could affect MAPK activity in Xenopus ectoderm.
In this paper, we show that BMP-4 inhibits MAP kinase
via a pathway dependent on TAK1 and a p38-like kinase.
Moreover, pharmacological inhibition of this pathway leads
to neural-specific gene expression in uninduced ectoderm.
Thus, BMP-4 signals interact antagonistically with FGF/
MAPK signals. Since FGFs and BMPs produce opposite
effects in many instances, including ectodermal specifica-
tion, limb outgrowth, tooth patterning, and lung develop-
ment, antagonistic crosstalk between these pathways may
play an important role in many developmental processes.
MATERIALS AND METHODS
Microinjection and Microsurgery
Preparation of embryos and microsurgical manipulations were
performed as described (Uzman et al., 1998). For overexpression
tudies, synthetic mRNA was prepared by in vitro transcription of
inearized plasmid DNA, using the Ambion mMessage mMachine
n vitro transcription system. Unless otherwise indicated, approxi-
ately 10 nl of mRNA stock at the appropriate concentration was
ressure-injected near the animal pole into each blastomere at the
-cell stage.
MAP Kinase Assays
MAP kinase assays were performed as described in Uzgare et al.
1998)), using the Xnf7 peptide as a substrate. Fifteen animal cap
solates (or equivalent) were used for each sample. Samples were
ysed and centrifuged for 20 min at 14,000 rpm before the assay;
ach sample was assayed in duplicate. Reaction mixtures were
eparated by Tris–tricine gel electrophoresis (Schagger and von
agow, 1987), and gels were cut to separate higher molecular weight
roteins from the lower region containing the substrate peptide.
he upper half was blotted to permit identification of MAP kinase
rotein by using an anti-MAP kinase antibody (generous gifts of J.
errell and J. Maller) and chemiluminescent detection. The lower
alf was autoradiographed to visualize the phosphorylated sub-
trate. Exposures for chemiluminescent detection and autoradiog-
aphy were kept within the linear range. Signals were quantified by
sing either scanning densitometry or OPTIMAS image analysis
oftware; identical results were obtained with both methods. A
atio of the phosphorylated substrate to MAP kinase provides a
easure of relative specific activity, which is then normalized tohat of isolated animal cap ectoderm expressing LacZ.
Copyright © 2001 by Academic Press. All rightTwo-Dimensional Gel Electrophoresis
Two-dimensional gel electrophoresis was performed as described
in Uzman et al. (1998). A sample containing 50 mg of protein was
loaded onto a urea gel and subjected to isoelectric focusing (IEF) for
at least 16 h. IEF gels were mounted above 10% gels for SDS–PAGE.
Western Blots
Immunoblotting was carried out as described in Uzman et al.
(1998). For detection of JNKs, 20 explants were lysed in kinase
buffer containing phosphatase inhibitors (Uzgare et al., 1998), and
centrifuged at 14,000 rpm at 4°C. Supernatants were then mixed
with concentrated SDS sample buffer, boiled, run on 10% SDS–
PAGE gels, and transferred to nitrocellulose. Blots were blocked in
5% milk in TBST before incubation with either anti-JNK or
anti-phospho-JNK antibodies (formerly New England Biolabs, now
Cell Signalling), diluted according to the manufacturer’s instruc-
tions. These antibodies have been used extensively to characterize
JNK activation (e.g., Alam et al., 2000). Blots were washed before
and after incubation with secondary antibody; all washes were
performed in TBST. Bands were visualized by chemiluminescent
detection (ECL).
RT-PCR
RNA isolation, preparation of cDNA, and polymerase chain
reaction assays (PCR) were carried out as described (Uzman et al.,
1998) using the primer sequences described therein. For each
sample, RNA was isolated from 15 animal caps or the equivalent.
The RT-PCR products were separated on 6% gels and visualized by
autoradiography.
Treatments with BMP-4, Cycloheximide, Sorbitol,
or SB 203580
A concentrated stock of recombinant human BMP-4 (generous
gift of the Genetics Institute) in glutamic acid buffer (0.5% sucrose,
2.5% glycine, 5 mM glutamic acid, 5 mM NaCl, 0.1% Tween 20,
pH 4.5) was prepared and stored as aliquots at 280°C until use.
Explants were treated with BMP-4 in 50% Ca21/Mg21-free medium
50% very low Ca21/Mg21 Ringer (CMFM:VLCMR) to prevent
ealing (Lamb and Harland, 1995); control explants were treated
ith 0.5 mg/ml bovine serum albumin in CMFM:VLCMR.
Cycloheximide treatments were performed as described in Uz-
are et al. (1998). For hyperosmotic treatments, embryos were
reated with 0.5 M sorbitol (Sigma) for 30 min and then lysed as
escribed.
SB 203580 (Calbiochem) was prepared as a stock in dimethyl
ulfoxide (DMSO) and diluted in CMFM:VLCMR immediately
efore use. Control explants were treated with an identical volume
f DMSO diluted in CMFM:VLCMR.
RESULTS
Inhibition of BMP-4 Signals Leads to an Increase in
MAPK Activity
Our earlier results indicated that MAP kinase activity
was elevated in midgastrula ectoderm overexpressing the
BMP-4 antagonist noggin (Uzgare et al., 1998). This finding
s of reproduction in any form reserved.
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261Inhibition of MAP Kinase by BMP-4/TAK1 Signalsimplicates the BMP-4 pathway in the negative regulation of
MAP kinase. To evaluate this hypothesis, we measured
MAP kinase activity in ectoderm overexpressing dominant
negative (Suzuki et al., 1994) or constitutively active (Su-
zuki et al., 1997) forms of the type I BMP-4 receptor.
We used an assay for MAP kinase activity that was
developed to measure activity in whole-cell lysates from
small amounts of tissue (Uzgare et al., 1998). This assay
uses a 2.8-kDa peptide representing the MAPK phosphory-
lation site in Xenopus nuclear factor 7 (Xnf7) (Reddy et al.,
991), in which all potential phosphorylation sites other
han the consensus MAPK site have been altered by site-
irected mutagenesis. A previous study has examined the
hosphorylation of this peptide in Xenopus oocyte extracts
El-Hodiri et al., 1997). The specificity of this assay is
upported by three findings. First, immunodepletion of
APK from oocyte extracts removes nearly all kinase assay
irected against this peptide, and the remainder is removed
y immunodepletion of cyclin B/cdc2 (El-Hodiri et al.,
997). Second, treatment of gastrula ectoderm with PD
98059 prior to addition of FGF reduced substrate phos-
horylation by approximately 90% (Uzgare et al., 1998). PD
98059 inhibits MAPK activation by preventing the activa-
ion of unphosphorylated MEK (MAP or ERK kinase, also
eferred to as MAPKK); it does not affect the activity of
hosphorylated MEK (Alessi et al., 1995), which may ac-
FIG. 1. Regulation of MAPK activity by overexpression of BMP-
eceptor leads to an increase in MAP kinase activity. Embryos wer
MP-4 receptor (TBR) or LacZ. Animal caps were isolated at the mi
inase activity. (B) In ectoderm overexpressing TBR, MAP kinase
SEM, n 5 3 experiments). For each experiment, RT-PCR assays we
gene expression (data not shown). (C) MAP kinase activity is
microinjected with mRNA encoding the constitutively active BMP
(1 ng). Animal ectoderm was isolated at st. 10 and assayed immedi
nearly 50% in ectoderm expressing CABR or TAK1. Overexpressio
independent experiments). For each experiment, RT-PCR assay
nhibited neural-specific gene expression (data not shown).ount for the remaining 10% of activity. Third, overexpres-
Copyright © 2001 by Academic Press. All rightion of MAP kinase phosphatase-1 (MKP-1) abolishes ki-
ase activity directed against this peptide in gastrula
ctoderm (Uzgare et al., 1998).
First, embryos were microinjected with 1 ng/embryo
RNA encoding either the dominant negative BMP-4 re-
eptor (TBR) or LacZ mRNA. Animal caps were isolated
rom the injected embryos, cultured until controls reached
t. 11 (midgastrula), and then assayed for MAP kinase
ctivity. MAP kinase activity is increased approximately
.5-fold in midgastrula ectoderm overexpressing the domi-
ant negative BMP-4 receptor (Fig. 1A). Additional isolates
ere cultured until st. 18, when they were collected for
NA isolation. RT-PCR assays confirmed that expression
f TBR leads to the expression of NCAM (data not shown),
emonstrating that the injected mRNA could be translated
o generate an active receptor.
Overexpression of BMP-4 Pathway Components
Leads to a Decrease in MAPK Activity
In the converse experiment, embryos were microinjected
with mRNA encoding a constitutively active BMP-4 recep-
tor (CABR) (250 pg/embryo), Smad1 (1 ng/embryo) (Thom-
sen, 1996), or TAK1 (1 ng/embryo) (Shibuya et al., 1998).
Animal caps were isolated from the injected embryos at
midblastula, cultured until intact controls reached st. 10,
hway components. (A) Expression of a dominant negative BMP-4
roinjected with 1 ng mRNA encoding either a dominant negative
tula stage, cultured until st. 11 (midgastrula), and assayed for MAP
ity is elevated 4.5-fold compared with control ectoderm (mean 6
formed to confirm that TBR expression resulted in neural-specific
bited by signaling through the BMP-4 receptor. Embryos were
ceptor type I (CABR, 250 pg), TAK1 (1 ng), Smad1 (1 ng), or LacZ
for MAP kinase activity. (D) MAP kinase activity is inhibited by
Smad1 has little effect on MAP kinase activity (mean 6 SEM, n 5
re performed to confirm that overexpression of Smad1 or CABR4 pat
e mic
dblas
activ
re per
inhi
-4 re
ately
n ofand then assayed for MAPK activity. Assays were per-
s of reproduction in any form reserved.
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262 Goswami, Uzgare, and Saterformed at st. 10 rather than st. 11, because our hypothesis
predicts that MAPK activity should decrease when the
BMP-4 pathway is active. MAPK activity is approximately
threefold higher in early gastrula ectoderm than in midgas-
trula ectoderm (Uzgare et al., 1998), so a decrease in activity
should be easier to detect at the earlier stage. RT-PCR
assays confirmed that overexpression of CABR or Smad1
inhibited otx2 expression compared to controls, indicating
hat both mRNAs were translated to form active proteins
data not shown).
MAPK activity is reduced by approximately 50% in early
astrula ectoderm expressing either CABR or TAK1 (Fig.
C). Ectoderm overexpressing Smad1, however, shows a
egligible decrease in MAPK activity. While overexpression
f TAK1 has been reported to promote cell death and
mbryonic lethality (Shibuya et al., 1998), significant cell
death was not observed within the time frame of these
experiments, and embryos expressing TAK1 often survived
to tailbud stages.
BMP-4 Inhibits MAPK Activity
Animal caps were isolated at midblastula, held in VL-
CMR to prevent healing, and treated with BMP-4 when
controls reached st. 10. Isolates were treated with BMP-4 at
concentrations ranging from 10 to 200 ng/ml and assayed
for MAPK activity after 20 min. MAPK activity decreased
to approximately 55% of control values in ectoderm treated
with 200 ng/ml BMP-4 (Fig. 2). This result indicates that the
inhibition of MAPK observed in the overexpression experi-
ments is not an artifactual result of prolonged overexpres-
sion of BMP-4 pathway components that might alter ex-
pression of ligands, receptors, or other upstream regulators
of MAPK.
Inhibition of MAPK by BMP-4/TAK1 Signals Is
Independent of Protein Synthesis
Regulation of MAPK by BMP-4 signals could occur di-
rectly via inhibitory crosstalk between BMP-4 pathway
components and regulators of MAPK. Alternatively, it
could involve an indirect mechanism, in which BMP-4
induces expression of a negative regulator of the MAPK
pathway. Both direct (Berrou et al., 1996) and indirect (King
et al., 1995) mechanisms of MAPK regulation by TGF-b
have been identified in different mammalian cell lines.
These mechanisms can be distinguished by assessing the
need for protein synthesis; inhibitory crosstalk should per-
sist in the absence of protein synthesis, while transcription-
dependent mechanisms should be sensitive to inhibitors of
protein synthesis.
We compared MAPK activity in ectoderm treated with
BMP-4 in the presence or absence of cycloheximide to
determine whether inhibition of MAPK by BMP-4 requires
protein synthesis. Animal caps were isolated from late
blastula embryos, and incubated in 5 mg/ml cycloheximide
or 30 min. At this concentration, greater than 95% of
Copyright © 2001 by Academic Press. All rightrotein synthesis is inhibited, and cycloheximide-resistant
rotein synthesis is confined primarily to the mitochondria
Cascio and Gurdon, 1987). Animal caps were then treated
ith 200 ng/ml BMP-4; control animal caps were treated
ith 200 ng/ml BSA. After 20 min, animal caps were
ollected and assayed for MAPK activity. Cycloheximide
as no effect on MAPK activity in either untreated ecto-
erm or ectoderm treated with BMP-4 (Fig. 3). Thus, inhi-
ition of MAPK activity by BMP-4 signaling is likely to
ccur via inhibitory crosstalk, rather than via the transcrip-
ional activation of negative regulators of the MAPK path-
ay.
Sustained Reduction in MAPK Activity and
Phosphorylation in Response to Endogenous
Signals
While BMP-4 signals cause a 50% reduction in MAPK
activity in early gastrula ectoderm, midgastrula uninduced
ectoderm shows an even lower level of MAPK activity,
relative to that of midgastrula neural ectoderm. We wished
to determine whether inhibitory crosstalk could account
for the entire reduction in MAPK activity. To evaluate the
sustained drop in MAPK activity in response to endogenous
BMP-4, MAPK activity was assayed in isolated animal caps
FIG. 2. Inhibition of MAPK activity by BMP-4. Animal cap
ectoderm was isolated from late blastula embryos and held in
VLCMR to prevent healing. When intact control embryos began to
gastrulate, the ectodermal isolates were treated with increasing
concentrations of BMP-4 for 20 min and then assayed for MAPK
activity. (A) Representative experiment showing MAP kinase and
phosphorylated substrate. (B) Relative MAPK activity in ectoderm
treated with BMP-4. SEM for ectoderm treated with 200 ng/ml
BMP-4 5 0.93; error bars are too small to appear on graph. (n $ 3
xperiments for each concentration tested; n 5 6 experiments
otal).cultured in the presence or absence of cycloheximide over a
s of reproduction in any form reserved.
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263Inhibition of MAP Kinase by BMP-4/TAK1 Signalstime course during the first half of gastrulation. Animal
caps were isolated from late blastula embryos, and cultured
in the presence or absence of cycloheximide; at intervals,
samples of 15 animal caps were removed and assayed for
MAPK activity. Activities were normalized to that of iso-
lated early gastrula ectoderm; samples of uninduced mid-
gastrula ectoderm and midgastrula neural ectoderm were
included for comparison (Fig. 4A). After 1.5 h, MAPK
activity is lower in cycloheximide-treated animal caps than
in untreated controls, indicating that protein synthesis is
required to maintain basal levels of MAPK activity. The
requirement for protein synthesis in the maintenance of
MAPK activity obscures any need for protein synthesis in
the longer-term inhibition of MAPK activity by BMP-4
signals. By the midgastrula stage, MAPK activity in unin-
duced ectoderm has dropped to approximately 30% of that
of early gastrula ectoderm, and it is one-fifth that of
midgastrula neural ectoderm.
We also examined MAPK phosphorylation in midgastrula
neural ectoderm and uninduced midgastrula ectoderm on
two-dimensional Western blots probed with an anti-MAPK
antibody. For uninduced midgastrula ectoderm, animal
caps were isolated from late blastula embryos and cultured
until sibling controls reached st. 11. Midgastrula neural
ectoderm was isolated from st. 11 embryos and included
primarily the presumptive anterior neural plate; the poste-
rior cut was placed well above the mesoderm–ectoderm
FIG. 3. Protein synthesis and the regulation of ectodermal MAPK
activity during gastrulation. Animal caps were isolated and incu-
bated with 5 mg/ml cycloheximide for 30 min before treatment
ith 200 ng/ml BMP-4. Assays for MAPK activity were performed
fter 20 min. (A) Representative experiment showing MAP kinase
nd phosphorylated substrate. (B) Relative MAPK activity in ecto-
erm treated with BMP-4 in the presence or absence of cyclohexi-
ide. (n 5 3 experiments).boundary to avoid inclusion of mesoderm. For each tissue, o
Copyright © 2001 by Academic Press. All right50-mg sample of protein was separated on 2-D gels and
ransferred to nitrocellulose, as described in Uzman et al.
1998).
On 2-D blots, MAPK resolves as two spots; the basic spot
epresents the nonphosphorylated protein, while the more
cidic spot represents the phospho-MAPK, which is phos-
horylated on threonine and tyrosine residues in the se-
uence TEY (Ferrell, 1996). The more acidic spot cross-
eacts with an anti-phosphotyrosine antibody (data not
hown). The phospho-MAPK constitutes a greater propor-
ion of the total MAPK in midgastrula neural ectoderm
han it does in uninduced ectoderm (Fig. 4B), indicating that
elative levels of phospho-MAPK decrease in response to
ndogenous BMP-4 and are elevated in response to endoge-
ous neural-inducing signals.
Characterization of the TAK1 Pathway
In mammalian cell types, TAK1 has been shown to
activate JNKs (Atfi et al., 1997; Shirakabe et al., 1997)
nd/or p38 (Hanafusa et al., 1999). Two experiments were
erformed to determine whether BMP-4/TAK1 signals lead
o the activation of either JNKs or a p38 homologue. First,
mmunoblots were performed to look for activated JNKs in
ctoderm in which BMP-4 signals were active. Embryos
ere injected with 1 ng/embryo mRNA encoding either
ABR, noggin, or LacZ, and animal caps were isolated
hen the embryos reached the beginning of gastrulation. As
positive control, we included 4-cell embryos treated with
.5 M sorbitol, as well as untreated 4-cell embryos. This
reatment has recently been shown to activate JNKs in
enopus oocytes (Bagowski et al., 2001). The tissues for
ach sample were lysed immediately, and proteins were
eparated by SDS–PAGE in duplicate and transferred to
itrocellulose. For each set of samples, one blot was probed
ith a polyclonal anti-JNK antibody, and the duplicate blot
as probed with a polyclonal anti-diphospho-JNK antibody.
ands were visualized by chemiluminescent detection.
Although two JNKs were detected in each sample, levels
f JNKs in gastrula ectoderm were relatively low, consis-
ent with the findings of Bagowski et al. (2001) that JNKs
re difficult to detect in postcleavage stage embryos (Fig. 5).
he diphospho-JNK in 4-cell embryos increased substan-
ially after exposure to sorbitol, as expected. However,
ctivated or diphospho-JNKs were barely detectable in
ysates of animal caps overexpressing CABR, and relative
iphospho-JNK levels in this sample were very similar to
hose of control ectoderm or ectoderm expressing noggin.
hile a small increase in diphospho-JNK levels was occa-
ionally observed in samples of ectoderm expressing CABR,
hese findings suggest that BMP-4/TAK1 signals do not lead
o a strong activation of JNKs in Xenopus ectoderm.
The second experiment was performed to determine
hether the p38 inhibitor SB 203580 would prevent the
nhibition of MAP kinase by TAK1. At low concentrations,
his compound is a highly specific inhibitor of p38 in vivo
r in vitro (Cuenda et al., 1995; for review, see Cohen,
s of reproduction in any form reserved.
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264 Goswami, Uzgare, and Sater1999). Low concentrations (e.g., 1 mM) of SB 203580 inhibit
p38 without affecting the activity of JNKs in vivo (Blair et
al., 1999) or in vitro (Gumet al., 1998). At concentrations of
10 mM or above, however, SB 203580 can inhibit some JNK
soforms in vitro (Clerk and Sugden, 1998), although at least
one in vivo study shows that mammalian JNKs are unaf-
fected by 10 mM SB 203580 (Blair et al., 1999). Thus,
FIG. 4. Effects of endogenous signals on MAPK activity and phos
of 5 mg/ml cycloheximide (CHX). Samples were assayed for MAP
equivalent to st. 11 (midgastrula); therefore, MAPK activity was a
(NP). Data are mean 6 SEM; error bars are shown where the SEM
0% in animal caps. After 3 h, MAPK activity is reduced to 30% o
oth the 1-h and 3-h intervals, ectoderm treated with CHX shows
B) Effects of endogenous signals on MAP kinase phosphorylation.
1 (AC st. 11); and neural plate ectoderm isolated at st. 11 (NP st.
two-dimensional gel electrophoresis and transferred to nitrocellulo
MAP kinase resolves into two spots; the more acidic spot (arrows)
FIG. 5. Detection of JNKs and phosphorylated JNKs in gastrula
ectoderm. Embryos were microinjected with 1 ng/embryo mRNA
encoding either the constitutively active BMP-4 receptor (CABR),
LacZ, or noggin (nog). Animal caps were isolated at st. 10, and lysed
in kinase assay buffer. As a control, 4-cell-stage embryos were
exposed to 0.5 M sorbitol for 15 min and then lysed. Both untreated
4-cell embryos (con) and treated embryos (sorb) are included to
show phosphorylation of p40 and p49 JNKs in response to hyper-
osmotic stress (Bagowski et al., 2001). The lysates were run on
DS–PAGE gels and transferred to nitrocellulose. The blots were
robed with antibodies directed against either Jun-N-terminal
inases (JNKs) or diphosphorylated JNKs (formerly New England
iolabs, now Cell Signalling). The slight increase in p40 diphospho-
NK does not occur consistently. Each lane represents 20 animal
aps (approximately 130 mg protein) or 10 whole embryos. (n 5 4experiments).
Copyright © 2001 by Academic Press. All right38-dependent events, but not those resulting from the
ctivation of JNKs, should be blocked by 1 mM SB 203580.
Embryos were injected with 1 ng/embryo mRNA encod-
ing either TAK1 or LacZ. Animal caps were isolated at late
blastula (st. 9.5) and held until st. 10, when they were
treated with either 1 mM SB 203580 in DMSO or DMSO
alone for 20 min. Tissues were then lysed and assayed for
MAPK activity.
Overexpression of TAK1 leads to a 45–50% drop in ectoder-
mal MAPK activity, in comparison with control ectoderm
expressing LacZ. When ectoderm overexpressing TAK1 is
treated with SB 203580, the drop in MAPK activity does not
occur, and MAPK activity resembles that of controls (Fig. 6).
Interestingly, when ectoderm expressing LacZ is treated with
SB 203580, MAPK activity increases by 35–40%. No addi-
tional increase is observed in ectoderm treated with 10 mM SB
203580, as would be expected if both JNKs and a p38 homo-
logue were inhibiting MAPK (data not shown).
These findings suggest that a p38 homologue mediates
the inhibition of MAPK activity by TAK1. The elevation of
MAPK activity in control ectoderm treated with SB 203580
might then result from the inhibition of endogenous BMP-
4/TAK1 signals. However, an alternative interpretation is
that a p38 homologue inhibits MAPK activity independent
of BMP-4/TAK1, and that the increase in MAPK activity
resulting from the inactivation of a p38 homologue masks
the inhibitory effects of TAK1 signaling.
The following experiment was performed to distinguish
ylation. (A) Animal caps were cultured in the presence or absence
tivity after 30 min, 1.5 h, and 3 h. At 3 h, the animal caps are
sayed in st. 11 uninduced ectoderm (AC) and st. 11 neural plates
eater than 3%. After 1 h, MAPK activity is reduced by more than
tial controls, comparable to that of st. 11 uninduced ectoderm. At
nificant drop in MAPK activity. (n 5 3 independent experiments).
es were prepared from ectoderm isolated at st. 9 and aged until st.
For each sample, a 50-mg aliquot of total protein was separated by
he blot was probed with anti-MAP kinase antibody. On 2-D blots,
esents the hyperphosphorylated form.phor
K ac
lso as
is gr
f ini
a sig
Lysat
11).between these possibilities. We examined the effects of SB
s of reproduction in any form reserved.
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265Inhibition of MAP Kinase by BMP-4/TAK1 Signals203580 on MAPK activity in ectoderm overexpressing nog-
gin or TBR. If endogenous BMP-4/TAK1 signals negatively
regulate MAPK activity via a p38 homologue, then overex-
pression of noggin or TBR should block endogenous signals
and lead to an increase in MAPK activity in early gastrula
ectoderm, as well as in midgastrula ectoderm, as shown in
Fig. 1A (Uzgare et al., 1998). Moreover, SB 203580 should
ave no effect on MAPK activity in ectoderm in which
MP-4 signaling is inhibited. Alternatively, if the inhibi-
ion of MAPK by a p38 homologue is independent of BMP-4
ignals, then treatment of ectoderm expressing noggin or
BR with the p38 inhibitor should cause an elevation in
APK activity, as it does in the previous experiments.
Embryos were injected with 1 ng mRNA encoding either
oggin, TBR, or LacZ. Animal caps were isolated at late
lastula, treated with 1 mM SB 203580, and assayed for
APK activity, as described. SB 203580 has no effect on
APK activity in ectoderm in which BMP-4 signals are
nactive, indicating that SB 203580 blocks a downstream
ffector of the BMP-4 pathway.
Inhibition of the BMP-4/TAK1/p38-Type Pathway
Leads to Neural Gene Expression
We sought to determine whether BMP-4 signaling via
FIG. 6. The p38 antagonist SB 203580 prevents the inhibition of
APK by TAK1. Embryos were injected with 1 ng LacZ or TAK1
RNA. Animal caps were isolated at st. 10 and treated with 1 mM SB
203580 for 20 min. They were then lysed and assayed for MAPK
activity. (n 5 4 independent experiments). In a second set of experi-
ments to determine whether the effects of SB 203580 are mediated by
the BMP-4 pathway, embryos were injected with 1 ng/embryo of
mRNA encoding LacZ, TBR, or noggin. Animal caps were isolated,
treated with 1 mM SB 203580, and assayed for MAPK activity as in the
previous experiment. (A) Representative experiments showing MAP
kinase and phosphorylated substrate. (B) Relative MAPK activities in
the presence or absence of SB 203580. SB 203580 blocks in the
inhibition of MAPK by TAK1; MAPK activity is unaffected by SB
203580 under conditions in which BMP-4 signals are inactive. (n 5 3
experiments for each sample, 6 experiments total).TAK1 and a p38 homologue is essential for the inhibition of
Copyright © 2001 by Academic Press. All righteural fate. Animal caps were isolated from late blastula
mbryos, treated with 1 mM SB 203580 when sibling control
mbryos reached early gastrula, and collected for RNA
solation and RT-PCR assays when controls reached the end
f gastrulation. Ectoderm treated with SB 203580 expresses
CAM, noggin, and increased levels of otx2, while, in
ntreated ectoderm, otx2 levels are low, and NCAM and
oggin are not detected (Fig. 7). These findings suggest that
AK1/p38-type signaling is essential for the inhibition of
eural fate by BMP-4.
DISCUSSION
We have shown that BMP-4 inhibits MAPK activity in
Xenopus gastrula ectoderm via a TAK1/p38-type kinase
pathway. This inhibition is independent of protein synthe-
sis, presumably occurring via inhibitory crosstalk between
the TAK1 and MAPK pathways. The simplest model is that
BMP-4/TAK1 signaling leads to the activation of a p38-type
effector kinase; the effector kinase would then activate a
phosphatase that could recognize and dephosphorylate
MAPK (Fig. 8A). Comparisons of phosphotyrosine-
containing proteins in early gastrula ectoderm, midgastrula
neural ectoderm, and uninduced midgastrula ectoderm in-
FIG. 7. Neural-specific gene expression in ectoderm treated with
SB 203580. Animal caps were isolated at the late blastula stage (st.
9) and treated with 1 mM SB 203580 when intact control embryos
eached st. 10. Tissues were cultured until control embryos reached
t. 12 and then collected for RNA isolation and RT-PCR. Otx2 and
noggin are expressed in the anterior neural plate in the late gastrula
(Vodicka and Gerhart, 1995); NCAM is expressed in the neural
ectoderm from midgastrula onwards (Uzman et al., 1998); muscle
actin and Xbra are assessed to detect the presence of mesoderm;
EF-1a primers flank an intron and are thus used to evaluate RNA
recovery and reveal any genomic DNA in each sample. (n 5 3
experiments).
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266 Goswami, Uzgare, and Saterdicate that there is a significant and widespread reduction
in protein tyrosine phosphorylation in nonneural ectoderm
during the first half of gastrulation (Uzman et al., 1998).
MAPK could be inactivated directly by a protein tyrosine
phosphatase.
Regulation of MAPK Activity in Early Gastrula
Ectoderm
Our results indicate that MAPK activity is regulated both
positively and negatively in early gastrula ectoderm. Dis-
ruption of the BMP-4/TAK1 pathway in ectoderm at the
onset of gastrulation results in elevated MAPK activity,
demonstrating that the inhibition of MAPK by BMP-4
signals is already underway. Ectodermal MAPK activity
increases from midblastula to early gastrula, suggesting
that MAPK is stimulated during this period by FGFs,
integrins, or other factors. Presumably, protein synthesis is
required for the continued responsiveness to positive regu-
lators of MAPK during gastrulation.
Additional mechanisms may participate in the long-term
decrease in MAPK activity in uninduced ectoderm during
the first half of gastrulation. First, dephosphorylation of
MEK could contribute to the decrease in MAPK activity. In
baboon smooth muscle cells, activation of p38 MAP kinase
leads to the inhibition of MEK via an indirect mechanism
(Daum et al., 1998). Second, expression of fibroblast growth
actor receptor-1 (FGFR1) decreases in isolated animal caps
FIG. 8. Model of inhibitory crosstalk between BMP-4 and FGF/M
he BMP-4 receptor complex activates TAK1, which then activates a
inase is a member of the MAPK family, possibly the p38-type MP
ctivates a phosphatase, either directly or indirectly, which then in
pidermal fate may be dictated by antagonistic interactions betwe
APK activity is kept low by the TAK1 pathway, which thus ma
ignals are inhibited by noggin or other antagonists, MAPK activity
ntagonistic interactions between BMP-4 and FGF signaling pathw
ells, which could sharpen spatial boundaries or stabilize nascentMusci et al., 1990; Friesel and Dawid, 1991), suggesting
Copyright © 2001 by Academic Press. All rightthat endogenous BMP-4 signals repress FGFR1 expression.
Since FGFs are thought to be major activators of MAPK in
Xenopus embryos (Christen and Slack, 1999), downregula-
tion of FGFR1 may be critical for the sustained drop in
MAPK activity in midgastrula uninduced ectoderm.
Interactions between MAPK and TGF-b Pathways
Among mammalian cell lines and vertebrate embryonic
cells, MAPK and TGF-b interact in a variety of ways. TGF-b
activates MAPK in embryonic chick ciliary ganglion cells
(Lhuillier and Dryer, 2000) and mammalian epithelial cell
lines (Hartsough and Mulder, 1995, 1997), while it inhibits
MAPK activity in eosinophils (Pazdrak et al., 1995) and
mooth muscle cells (Berrou et al., 1996). In some cases,
inhibition of MAPK by TGF-b occurs via a transcriptional
activation of MKP (also known as CL100) (King et al., 1995).
In contrast, short-term inhibition of MAPK by TGF-b
signaling is independent of protein synthesis in smooth
muscle cells (Berrou et al., 1996). Moreover, in some cell
types, MAPK activity is unaffected by TGF-b. To our
nowledge, regulation of MAPK by BMP-4 has not previ-
usly been reported.
BMP-4/TAK1 Effector Kinases
The identity of the BMP-4/TAK1 effector kinase in Xe-
nopus ectoderm has yet to be resolved. BMP-4/TAK1 path-
pathways. (A) The pathway of inhibition: upon binding of BMP-4,
ector kinase via an unknown MAPKK family member. The effector
another p38-type kinase, or NLK. This effector kinase presumably
ates MAPK. (B) In ectoderm cells, the establishment of neural vs.
MP-4 and FGF signaling pathways. Where BMP-4 signals prevail,
vent MAPK from interfering with Smad1 activity. Where BMP-4
eases and may bring about a rapid reduction in Smad1 activity. (C)
may prevent a simultaneous flux of both signals within individual
s of developmental commitment.APK
n eff
K2,
activ
en B
y pre
incrways have been shown to activate either JNKs (Atfi et al.,
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267Inhibition of MAP Kinase by BMP-4/TAK1 Signals1997; Shirakabe et al., 1997), p38 MAP kinases (Hanafusa et
l., 1999), or Nemo-like kinase (NLK). A recent study has
dentified two major Xenopus JNKs, at 40 and 49 kDa
Bagowski et al., 2001). Both JNKs are present in oocytes
nd cleavage-stage embryos, and the levels of each JNK drop
ignificantly during the blastula stage. In oocytes, these
NKs are activated by hyperosmolar conditions and by a
APK-dependent pathway. A p38/HOG 1-type MAPK,
nown as reactivating kinase (RK) or MPK2, has been
solated from Xenopus oocytes (Rouse et al., 1994).
Several findings suggest that the BMP-4/TAK1 effector
inase is more likely to be a p38/RK-type kinase than a
NK. First, levels of JNKs are very low by the onset of
astrulation (Bagowski et al., 2001). Second, our results
uggest that JNKs are not regulated by BMP-4 signals in
astrula ectoderm, since very little diphospho-JNK was
etected in ectoderm, whether BMP-4 signals were active or
nactive. Third, the inhibition of MAPK is prevented by the
38 antagonist SB 203580.
The specificity of SB 203580, a pyridinyl imidazole de-
ivative, has been extensively characterized. Structural
nalyses of mammalian p38 MAPK complexed with drugs
f this group indicate that the pyridinyl imidazole antago-
ists interact with a specific threonine residue (T106)
ithin part of the ATP binding site (DVYLVTHLMG; Eyers
t al., 1998). The sequence of RK/MPK2 at this site (Rouse
t al., 1994) is identical to that of the mammalian p38
equence, indicating that RK/MPK2 should be sensitive to
yridinyl imidazole inhibitors such as SB 203580. Both
ammalian (Eyers et al., 1998) and amphibian (Gotoh et
l., 1991) ERK MAPKs lack a threonine at this position,
ubstituting a glutamine. A comparison of human (Ito et al.,
999), mouse (Sluss et al., 1994), chicken (Ishikawa et al.,
997), carp (Hashimoto et al., 1997), and Drosphila (Riesgo-
scovar et al., 1996) JNKs shows that the corresponding
equence is DVYLVMELMD, thus substituting a methio-
ine for the critical threonine. This sequence is identical
cross the species surveyed; thus, while Xenopus JNKs have
ot yet been cloned, it is likely that they will retain this
otif. Although mammalian NLKs carry the conserved
hreonine residue (Brott et al., 1998; Kehrer-Sawatzki et al.,
000), the remainder of the corresponding sequences within
putative ATP-binding site for mammalian NLKs are so
ivergent that it is impossible to predict whether these
inases would be sensitive to pyridinyl imidazole inhibi-
ors. A sequence for Xenopus NLK has not been reported to
ate.
These comparisons indicate that the SB 203580-sensitive
ffector of TAK1 is a p38-type kinase, rather than a member
f the JNK subfamily. The effects of SB 203580 on neural-
pecific gene expression have an additional caveat, how-
ver: at higher concentrations (e.g., 30 mM), SB 203580 has
been shown to inhibit the type I TGF-b receptor (Eyers et
al., 1998), and thus it could conceivably inhibit the type I
BMP-4 receptor. Studies are now in progress to determine
whether the Xenopus Type I BMP-4 receptor is inhibited by
1 mM SB 203580.
Copyright © 2001 by Academic Press. All rightAntagonistic Interactions between MAPK and
BMP-4: Neural Specification and Beyond
The inhibition of MAPK by BMP-4 may play a significant
role in the regulation of neural fate. Our previous results
indicate that MAPK is necessary for the establishment of
neural fate in response to endogenous signals (Uzgare et al.,
1998). MAPK has been shown to inhibit the BMP-4 effector
Smad1 in mammalian cells (Kretzschmar et al., 1997). We
have found that disruptions in the MAPK phosphorylation
sites of Smad1 act collectively as a gain-of-function muta-
tion in axis determination and neural specification, suggest-
ing that MAPK or other proline-directed kinases inhibit
Smad1 in vivo (A.K.S. et al., unpublished observations). In
ventral ectoderm, BMP-4 may prevent MAPK activity from
increasing above the threshold at which MAPK can inter-
fere with Smad1 activity or activate other targets that could
mediate neural specification. In dorsal ectoderm, inhibition
of BMP-4 signaling by extracellular BMP antagonists leads
to an increase in MAPK activity, which presumably accel-
erates the inhibition of BMP-4/Smad1 signals via inhibitory
phosphorylation of Smad1 (Fig. 8B). If MAPK functions in
neural specification primarily to hasten the decline in
BMP-4/Smad1 signaling once BMP-4 antagonists are
present, then MAPK activity may not be necessary under
experimental conditions in which BMP-4 signaling is never
activated (e.g., in ectoderm overexpressing noggin). Support
for this idea comes from our previous finding that MAPK
activity is not required for neural gene expression in ecto-
derm overexpressing noggin (Uzgare et al., 1998).
Antagonistic interactions between MAPK and BMP-4
pathways may underlie a wide range of developmental
processes in which FGFs and BMPs have opposing effects.
In the limb bud, FGF-2 stimulates cell proliferation,
whereas BMP4 triggers withdrawal from the cell cycle
(Niswander and Martin, 1993). At later stages, BMP-4
induces chondrogenesis, while FGFs can block BMP-4-
induced chondrogenesis (Buckland et al., 1998). Similarly,
apoptosis in the mammalian embryonic heart is stimulated
by BMP4 and inhibited by FGF2 (Zhao and Rivkees, 2000).
FGF10 promotes proliferation and outgrowth of the mouse
lung bud epithelium, while BMP-4 inhibits proliferation
and blocks budding elicited by FGF10 (Weaver et al., 2000).
Alternating regions of BMP and FGF expression specify the
positioning of tooth primordia in mouse embryos (Neu-
buser et al., 1997) and feather germs in the chick (Jung et al.,
1998). BMP-4 induces blood formation in amphibian ventral
mesoderm, while FGF inhibits blood differentiation (Xu et
al., 1999).
In each of these examples, inhibitory crosstalk could
ensure that cells do not simultaneously experience high
levels of signaling from opposing pathways, which could
delay or prevent developmental commitment. Mutually
antagonistic interactions between these pathways could
sharpen spatial boundaries or thresholds of developmental
commitment (Fig. 8C). In some cases, these interactions
s of reproduction in any form reserved.
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grammed cell death.
In some developmental processes, BMPs and FGFs act
cooperatively to promote specific cell fates. The combined
action of BMP-4 and FGF-2/4 is required to induce expres-
sion of cardiac-specific transcription factors in avian non-
precardiac mesoderm (Barron et al., 2000). Both FGF8 and
BMPs are necessary for the differentiation of specific nor-
adrenergic neuronal populations in the zebrafish hindbrain
(Guo et al., 1999). In these instances, the cooperative effects
of FGFs and BMPs are highly sensitive to the concentra-
tions of one or both factors, with an optimal concentration
that may be lower than the maximal concentration. This
may suggest that antagonistic crosstalk could modulate the
strength of signaling through either pathway to an optimal
level for a given developmental outcome. Alternatively,
inhibition of MAPK by BMP-4 signaling may be dependent
on expression of specific pathway components (e.g., effector
kinase, phosphatase), which may not be present in tissues
where cooperative effects are observed.
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